Immucell Corp (ICCC) Swings to Q2 Profit
Tweet
Share
E-mailGet Alerts ICCC Hot Sheet
Price: $9.75 +2.74%
Financial Fact:
Diluted (in dollars per share): 0.01
Today's EPS Names:
OCCI, MAYS, CRMT, More
Financial Fact:
Diluted (in dollars per share): 0.01
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Immucell Corp (NASDAQ: ICCC) reported Q2 EPS of $0.01, versus ($0.09) reported last year. Revenue for the quarter came in at $1.18 million, versus $1.25 million reported last year.
The Estimize consensus was $0.00 and $0 , respectively.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
The Estimize consensus was $0.00 and $0 , respectively.
For earnings history and earnings-related data on Immucell Corp (ICCC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- JPMorgan Starts ICICI Prudential Asset Management (ICICIAMC:IN) at Overweight
- Alphabet slides over 6% as AI brain drain and SpaceX slump converge
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
